Cutler Group LP Lexicon Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2018 Nov 07, 2018	SELL	$10.32 - $13.06 $4,128 - $5,224	-400 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$7.86 - $11.39 $82,530 - $119,595	-10,500 Reduced 96.33%	400 $0
Q4 2017 Jan 17, 2018	SELL	$8.77 - $12.28 $487,612 - $682,768	-55,600 Reduced 83.61%	10,900 $0
Q3 2017 Oct 17, 2017	BUY	$12.17 - $16.3 $809,305 - $1.08 Million	66,500	66,500 $7,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.